
Sign up to save your podcasts
Or


For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/EEY865. CME/AAPA credit will be available until November 24, 2025.
A New Script for SCD Care: Guidance on Patient-Centric Treatment Decisions With Innovative Therapeutics
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Sickle Cell Disease Association of America, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from Agios Pharmaceuticals, Inc., and Novo Nordisk Inc.
Disclosure information is available at the beginning of the video presentation.
By PVI, PeerView Institute for Medical Education4.1
2525 ratings
For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/EEY865. CME/AAPA credit will be available until November 24, 2025.
A New Script for SCD Care: Guidance on Patient-Centric Treatment Decisions With Innovative Therapeutics
In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and Sickle Cell Disease Association of America, Inc. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by independent educational grants from Agios Pharmaceuticals, Inc., and Novo Nordisk Inc.
Disclosure information is available at the beginning of the video presentation.

43,543 Listeners

137 Listeners

320 Listeners

698 Listeners

497 Listeners

29 Listeners

11 Listeners

1,384 Listeners

5 Listeners

11 Listeners

3 Listeners

2 Listeners

5 Listeners

2 Listeners

3 Listeners

5 Listeners

5 Listeners

2 Listeners

0 Listeners

9 Listeners

2 Listeners

11 Listeners

2 Listeners

882 Listeners

4 Listeners

3 Listeners

5 Listeners

3,347 Listeners

1,146 Listeners

193 Listeners

92 Listeners

515 Listeners

370 Listeners

426 Listeners